BRAINSWAY LTD-ADR (BWAY)
US10501L1061 - ADR
BrainsWay Reports Positive Independent Pilot Data on Accelerated Deep TMS Treatment of Alcohol Use Disorder
BURLINGTON, Mass. and JERUSALEM, Dec. 12, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global...
BrainsWay Reports Promising Feasibility Data Showing Pain Reduction with Deep TMS Therapy
Reductions also seen in comorbid anxiety and depression symptoms...
BrainsWay Reports Third Quarter 2024 Financial Results and Operational Highlights
Robust 26% Year-over-Year Revenue Growth in Q3 2024 Raising Full-Year 2024 Revenue Guidance to $40-41 Million and Initiating Profitability Guidance ...
BrainsWay to Report Third Quarter 2024 Financial Results On November 12, 2024
BURLINGTON, Mass. and JERUSALEM, Oct. 29, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global...
BrainsWay Further Penetrates East Asia with Placement of 15 Additional Deep TMS™ Systems in Taiwan and South Korea
BURLINGTON, Mass. and JERUSALEM, Israel, Oct. 09, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a...
BrainsWay Announces US$20 Million Private Placement with Valor Equity Partners
Company to leverage capital and Valor’s expertise for strategic initiatives building market awareness, R&D roadmap, data analysis capabilities, and...
BrainsWay Announces Significant Expansion on U.S. East Coast
14 Deep TMS™ Devices Ordered by Large Mental Health Network...
Israel Ministry of Defense Clears BrainsWay Deep TMS™ for PTSD Reimbursement at Israeli Hospitals
BURLINGTON, Mass. and JERUSALEM, Israel, Sept. 10, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a...
BrainsWay Appoints Richard A. Bermudes, M.D. as Chief Medical Officer
Dr. Bermudes is Widely Considered One of the Preeminent U.S. ...
BWAY Stock Earnings: BrainsWay Beats Revenue for Q2 2024
BWAY stock results show that BrainsWay beat on revenue for the second quarter of 2024.
BrainsWay Reports Second Quarter 2024 Financial Results and Operational Highlights
Generated Robust 28% Year-over-Year Revenue Growth in Q2 2024 Recorded Positive Quarterly Net Income for Third Consecutive Quarter, and Positive Adjusted...
BrainsWay to Report Second Quarter 2024 Financial Results on August 6, 2024
BURLINGTON, Mass. and JERUSALEM, July 23, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global...
BrainsWay Expands Global Imprint with Exclusive Multi-Year Distribution Agreement in Canada
BURLINGTON, Mass. and JERUSALEM, June 17, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global...
Small-Cap Standouts: 3 Stocks Destined to Rule Their Industries
Undervalued small-cap stocks are en masse. Consider these three best-in-class small-class gems before other investors latch onto them!
BrainsWay Launches Prospective, Randomized, Controlled, Multicenter Trial Evaluating Accelerated Deep TMS™ for Depression
Shortened Acute Treatment Period Could Enhance Appeal and Market Opportunities of Deep TMS™...
BrainsWay Receives Expanded FDA Labeling to Treat Late Life Depression
Deep TMS™ Becomes the First and Only TMS Device Indicated for Depression Treatment in Patients Between the Ages of 68 and 86...
BWAY Stock Earnings: BrainsWay Beats Revenue for Q1 2024
BWAY stock results show that BrainsWay beat on revenue for the first quarter of 2024.
BrainsWay Reports First Quarter 2024 Financial Results and Operational Highlights
Generated Significant 37% Year-over-Year Revenue Growth in Q1 2024 Recorded Positive Quarterly Net Income for Second Consecutive Quarter, and Positive...
BrainsWay to Report First Quarter 2024 Financial Results on May 8, 2024
BURLINGTON, Mass. and JERUSALEM, April 24, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global...
BrainsWay Announces Published Review Results Highlighting Potential of Deep TMS™ to Treat Parkinson's Disease
Clinical Data from Multiple Trials Showed Improvements in Both Motor and Non-Motor Symptoms...
BrainsWay Broadens Partnership with Katie’s Way Plus Through Order of an Additional 18 Deep TMS™ Systems
Katie’s Way Provides Lifesaving Mental Health Treatment Nationally with a Focus on Servicemembers, Veterans, and their Families...
Low-Priced, High-Potential: 7 Cheap Stocks Under $10 to Try Your Luck With
Although lesser-known ideas present high risks, these cheap stocks under $10 could be intriguing for the calculating speculator.
BWAY Stock Earnings: BrainsWay Beats Revenue for Q4 2023
BWAY stock results show that BrainsWay beat on revenue for the fourth quarter of 2023.
BWAY Stock Earnings: BrainsWay Beats Revenue for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips BrainsWay (NASDAQ:BWAY) just reported results for the fourth quarter of 2023.Th...
BrainsWay Reports Fourth Quarter and Full-Year 2023 Financial Results and Operational Highlights
Generated Record Revenues with Robust 50% Year-over-Year Revenue Growth in Q4 2023; Generated Positive Quarterly Net Income Providing Full-Year 2024...
BrainsWay to Report Fourth Quarter and Full Year 2023 Financial Results on March 6, 2024
BURLINGTON, Mass. and JERUSALEM, Feb. 21, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global...
7 High-Growth Stocks to Snag for Spectacular Returns in 2024
Discover 2024's top seven high-growth stocks, blending innovative tech, strategic scalability, and market dominance for high returns.
Biotech Stocks Are on Fire: Here Are the Top 3 Picks for January
These biotech stocks offer exciting and disruptive solutions with the potential to expand to market caps worth trillions.
7 Under-the-Radar Stocks Gearing Up for a 2025 Breakthrough
Are you looking to invest in under-the-radar stocks? Here are seven under-the-radar stocks gearing up for a 2025 breakthrough.
BrainsWay Highlights Expanded Deep TMS™ Access with Growing Western U.S. Network
BURLINGTON, Mass. and JERUSALEM, Dec. 19, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global...
BrainsWay Announces Continued Expansion of Deep TMS™ in South Korea
BURLINGTON, Mass. and JERUSALEM, Dec. 07, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global...
Market Mavericks: 3 Stocks That Could Turn $10K into $100K by 2027
Are you looking for stock multibaggers with high potential? Here are three stocks that could turn $10k into $100k by 2027.
Louisiana Insurer Expands Deep TMS™ Access for 1.9 Million Covered Lives
BURLINGTON, Mass. and JERUSALEM, Nov. 20, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global...